D. Kirk Ways

2.6k total citations
44 papers, 2.3k citations indexed

About

D. Kirk Ways is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Immunology. According to data from OpenAlex, D. Kirk Ways has authored 44 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 6 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Immunology. Recurrent topics in D. Kirk Ways's work include Protein Kinase Regulation and GTPase Signaling (11 papers), Plant biochemistry and biosynthesis (6 papers) and Ubiquitin and proteasome pathways (5 papers). D. Kirk Ways is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (11 papers), Plant biochemistry and biosynthesis (6 papers) and Ubiquitin and proteasome pathways (5 papers). D. Kirk Ways collaborates with scholars based in United States, United Kingdom and Hungary. D. Kirk Ways's co-authors include Peter J. Parker, Paul Cook, Daisuke Koya, George L. King, Michael R. Jirousek, Donald J. Fletcher, Jerry L. Hooker, Hisao Wakasaki, Richard A. Walsh and Frederick J. Schoen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

D. Kirk Ways

44 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Kirk Ways United States 24 1.6k 288 269 221 211 44 2.3k
Whaseon Lee‐Kwon United States 28 1.6k 1.0× 156 0.5× 377 1.4× 371 1.7× 251 1.2× 56 2.5k
Rüdiger von Harsdorf Germany 27 1.6k 1.0× 613 2.1× 330 1.2× 198 0.9× 253 1.2× 36 2.7k
Ken I. Mitchelhill Australia 20 2.6k 1.6× 369 1.3× 239 0.9× 237 1.1× 279 1.3× 25 3.5k
David G. Campbell United Kingdom 18 1.9k 1.2× 111 0.4× 162 0.6× 406 1.8× 129 0.6× 18 2.5k
G W Dorn United States 24 1.7k 1.1× 728 2.5× 112 0.4× 147 0.7× 272 1.3× 46 2.6k
Tim T. Lam United States 31 1.9k 1.2× 121 0.4× 151 0.6× 201 0.9× 122 0.6× 77 3.3k
Nicola Perrotti Italy 30 1.4k 0.9× 202 0.7× 228 0.8× 156 0.7× 304 1.4× 92 2.4k
Louise Larose Canada 29 1.4k 0.9× 113 0.4× 226 0.8× 607 2.7× 86 0.4× 74 2.3k
Kotaro Numaguchi Japan 13 846 0.5× 447 1.6× 149 0.6× 137 0.6× 89 0.4× 22 1.5k
Soo Mi Kim United States 27 1.5k 1.0× 348 1.2× 562 2.1× 585 2.6× 343 1.6× 56 2.7k

Countries citing papers authored by D. Kirk Ways

Since Specialization
Citations

This map shows the geographic impact of D. Kirk Ways's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Kirk Ways with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Kirk Ways more than expected).

Fields of papers citing papers by D. Kirk Ways

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Kirk Ways. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Kirk Ways. The network helps show where D. Kirk Ways may publish in the future.

Co-authorship network of co-authors of D. Kirk Ways

This figure shows the co-authorship network connecting the top 25 collaborators of D. Kirk Ways. A scholar is included among the top collaborators of D. Kirk Ways based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Kirk Ways. D. Kirk Ways is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sipeki, Szabolcs, et al.. (2000). Protein kinase C decreases the hepatocyte growth factor-induced activation of Erk1/Erk2 MAP kinases. Cellular Signalling. 12(8). 549–555. 12 indexed citations
3.
Ways, D. Kirk & Matthew J. Sheetz. (2000). The role of protein kinase C in the development of the complications of diabetes. Vitamins and hormones. 60. 149–193. 47 indexed citations
4.
Sipeki, Szabolcs, et al.. (1999). Phosphatidylinositol 3-kinase Contributes to Erk1/Erk2 MAP Kinase Activation Associated with Hepatocyte Growth Factor-induced Cell Scattering. Cellular Signalling. 11(12). 885–890. 64 indexed citations
5.
Samokhin, Gennady P., Michael R. Jirousek, D. Kirk Ways, & Ruth Ann Henriksen. (1999). Effects of protein kinase C inhibitors on thromboxane production by thrombin-stimulated platelets. European Journal of Pharmacology. 386(2-3). 297–303. 9 indexed citations
6.
DeVente, James, et al.. (1996). Transcriptional Regulation of Insulin Receptor Substrate 1 by Protein Kinase C. Journal of Biological Chemistry. 271(50). 32276–32280. 27 indexed citations
7.
Mukherjee, Jagat J., Taeowan Chung, D. Kirk Ways, & Zoltán Kiss. (1996). Protein Kinase Cα Is a Major Mediator of the Stimulatory Effect of Phorbol Ester on Phospholipase D-mediated Hydrolysis of Phosphatidylethanolamine. Journal of Biological Chemistry. 271(46). 28912–28917. 33 indexed citations
8.
Lee, Yong J., Sandra Galoforo, Christine M. Berns, et al.. (1995). Effect of Ionizing Radiation on AP-1 Binding Activity and Basic Fibroblast Growth Factor Gene Expression in Drug-sensitive Human Breast Carcinoma MCF-7 and Multidrug-resistant MCF-7/ADR Cells. Journal of Biological Chemistry. 270(48). 28790–28796. 52 indexed citations
9.
Ways, D. Kirk, Cindy Kukoly, James DeVente, et al.. (1995). MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype.. Journal of Clinical Investigation. 95(4). 1906–1915. 239 indexed citations
11.
Ways, D. Kirk, Karla J. Posekany, James DeVente, et al.. (1994). Overexpression of protein kinase C-zeta stimulates leukemic cell differentiation.. PubMed. 5(11). 1195–203. 53 indexed citations
12.
Kiley, Susan C., Andrée R. Olivier, W. Jonathan Ryves, et al.. (1994). 12-Deoxyphorbol-13-O-phenylacetate-20-acetate is not protein kinase C-β isozyme-selective in vivo. Carcinogenesis. 15(2). 319–324. 21 indexed citations
13.
Terrian, David M., et al.. (1993). Transduction of a protein kinase C‐generated signal into the long‐lasting facilitation of glutamate release. Hippocampus. 3(2). 205–220. 18 indexed citations
15.
Cook, Paul, Jianming Chen, & D. Kirk Ways. (1992). Interleukin-3 induces translocation and down-regulation of protein kinase C in human platelets. Biochemical and Biophysical Research Communications. 185(2). 670–675. 8 indexed citations
16.
Cooper, Denise R., James Watson, Bingzhi Yu, et al.. (1992). Direct evidence for protein kinase c involvement in insulin-stimulated hexose uptake. Biochemical and Biophysical Research Communications. 188(1). 142–148. 14 indexed citations
17.
Terrian, David M., D. Kirk Ways, & Robert L. Gannon. (1991). A presynaptic role for protein kinase C in hippocampal mossy fiber synaptic transmission. Hippocampus. 1(3). 303–314. 34 indexed citations
18.
19.
Ways, D. Kirk, et al.. (1988). Effect of retinoic acid on phorbol ester-stimulated differentiation and protein kinase C-dependent phosphorylation in the U937 human monoblastoid cell.. PubMed. 48(20). 5779–87. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026